Article citationsMore>>

Rybak, M.J., Lomaestro, B.M., Rotschafer, J.C., Moellering Jr., R.C., Craig, W.A., Billeter, M., Dalovisio, J.R. and Levine, D.P. (2009) Therapeutic Monitoring of Vancomycin in Adults Summary of Consensus Recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy, 29, 1275-1279. http://dx.doi.org/10.1592/phco.29.11.1275

has been cited by the following article:

• TITLE: The Prevalence of Methicillin-Resistant Staphylococcus aureus Colonization in Patients with Complicated Skin and Skin Structure Infections after Treatment with Linezolid or Vancomycin

  AUTHORS: Laura A. Puzniak, Kimbal D. Ford, David B. Huang

  KEYWORDS: Staphylococcus aureus, Complicated Skin and Skin Structure Infection, Colonization, Linezolid

  JOURNAL NAME: Advances in Infectious Diseases, Vol.4 No.4, November 28, 2014

  ABSTRACT: Background: Complicated skin and skin structure infections (cSSSIs) due to Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), are associated with significant morbidity. Re-ducing MRSA carriage has been a focus of infection control interventions. The prevalence of MRSA colonization after successful treatment of a MRSA cSSSI is unknown. Methods: Secondary analysis of a randomized controlled trial comparing linezolid and vancomycin for the treatment of MRSA cSSSI. Adult patients that had a colonization culture, confirmed MRSA cSSSI, received at least one dose of study treatment, and had an outcome recorded at end of study. Patient, clinical characteristics and prevalence of colonization were compared by treatment regimens. A multivariate regression model identified predictors of MRSA colonization at EOS. Results: There were 456 patients evaluated. The prevalence of MRSA colonization was higher for vancomycin treated patients compared to linezolid treated patients at end of treatment (EOT) (28% vs. 5%, p